StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
DNAMEDIA.BO$3.01+3.08%
Fair $3.01+0.0%

DNAMEDIA.BO

Diligent Media Corporation Limited

Communication Services / PublishingBSE

$3.01

+0.09 (+3.08%)

Fairly Valued+0.0%Fair Value $3.01Fund rank 27/100 · Data gapFallback financials|
SA 30/D
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $29.3M · quality 46.3/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 20/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

30/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -5.6%, below the 5% threshold
Thesis & Journal · DNAMEDIA.BOLocal privado en este navegador · Diligent Media Corporation Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$354M

P/E

30.1x

↑

EV/EBITDA

31.6x

↑

ROE

-5.6%

↓

Gross Margin

92.2%

↑

Debt/Equity

-1.79

↓
52-Week Range$3
$2$6

TradingView lightweight chart

DNAMEDIA.BO price, volumen y niveles de valoración

Último $3.010Periodo -72.9%
Fair value: $3.010

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+26.7%

FCF CAGR

+69.7%

FCF margin

22.2%

FCF / Net income

0.22x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $131.9M · net income $136.2M · FCF $29.3M

2022-FY → 2025-FY

Gross margin

92.2%-7.7% pts

Operating margin

17.3%+135.4% pts

Net margin

103.2%-266.1% pts

FCF margin

22.2%+13.0% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$131.9M$131.9M$97.0M$94.4M$64.8M
Net Income$136.2M$136.2M$1.37B$1.61B$239.5M
EBITDA$148.8M$148.8M$1.79B$1.28B$-76.6M
EPS1.161.1611.6213.652.03
Gross Margin92.2%92.2%97.4%100.0%100.0%
Operating Margin17.3%17.3%-85.9%-94.6%-118.2%
Net Margin103.2%103.2%1410.2%1701.6%369.4%
Balance Sheet
Debt/Equity-1.79-1.79-1.69-1.11—
Current Ratio42.1642.16———
Cash Flow
Free Cash Flow$29.3M$29.3M$-60.8M$926.9M$6.0M
Returns
ROE-5.6%-5.6%-53.2%-40.8%-4.3%
Valuation
P/E30.1030.100.390.191.51
EV/EBITDA31.5931.592.733.64—
Growth & Yield
Revenue Growth36.0%36.0%2.7%45.7%—
EPS Growth-90.0%-90.0%-14.9%572.4%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-38.7%

fácil

EPS terminal req.

$0.27

Spread vs growth

-51.3%

5Y implied EPS CAGR

-22.6%

fácil

EPS terminal req.

$0.32

Spread vs growth

-67.5%

10Y implied EPS CAGR

-7.7%

fácil

EPS terminal req.

$0.52

Spread vs growth

-82.3%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -39.8%

Total return

-39.8%

Start / end P/E

0.4x → 2.6x

EPS bridge

11.62 → 1.16

Residual

-452.8%

EPS growth-90.0%
Multiple rerating+503.0%
Dividend+0.0%
Residual / FX / buybacks / cross-term-452.8%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.